Candel Therapeutics (CADL) FCF Margin (2020 - 2022)
Candel Therapeutics recorded quarterly FCF Margin of 21590.32% in Q4 2022, up 24.28% quarter-over-quarter from 28512.9% in Q3 2022, and up 7410968.0% year-over-year from N/an in Q4 2021.
Candel Therapeutics' FCF Margin history runs 3 years deep, the most recent figure standing at 21590.32% for Q4 2022.
- In Q4 2022, FCF Margin rose 7410968.0% year-over-year to 21590.32%; the TTM figure through Dec 2022 stood at 25393.55% (down 109759.0% YoY), while the FY2022 annual figure was 25190.4%, down 113740.0% from the prior year.
- FCF Margin came in at 21590.32% for Q4 2022 at Candel Therapeutics, up from 28512.9% in the prior quarter.
- In the past five years, FCF Margin ranged from a high of 4119.35% in Q3 2020 to a low of 95700.0% in Q4 2021.
- A 3-year average of 27601.94% and a median of 23811.29% in 2021 frame the typical range for FCF Margin.
- Across the five-year window, FCF Margin tumbled 8014194 bps in 2021 and surged 7410968 bps in 2022, its largest moves.
- Candel Therapeutics' FCF Margin stood at 15558.06% in 2020, then tumbled by 515 bps to 95700.0% in 2021, then surged by 77 bps to 21590.32% in 2022.
- According to Business Quant data, FCF Margin over the past three periods registered 21590.32%, 28512.9%, and 24135.48% for Q4 2022, Q3 2022, and Q2 2022 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -3.98% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 43.35% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 23.53% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 4.17% |
| 10 | Candel Therapeutics | 449.62 Mn | 449.62 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | -21,590.32% |
| Sep 30, 2022 | -28,512.90% |
| Jun 30, 2022 | -24,135.48% |
| Mar 31, 2022 | -27,335.48% |
| Dec 31, 2021 | -95,700.00% |
| Sep 30, 2021 | -23,503.23% |
| Jun 30, 2021 | -11,445.16% |
| Mar 31, 2021 | -24,119.35% |
| Dec 31, 2020 | -15,558.06% |
| Sep 30, 2020 | -4,119.35% |